Beta Bionics Raises FY2026 Sales Guidance from $121.000M-$126.000M to $124.000M-$126.000M vs $126.626M Est

Benzinga · 2d ago
Beta Bionics (NASDAQ:BBNX) raises FY2026 sales outlook from $121.000 million-$126.000 million to $124.000 million-$126.000 million vs $126.626 million estimate.